1) non-small cell
非小细胞
1.
Detection of phosphorylated AKT expression and cell proliferation in non-small cell lung cancer tissue;
非小细胞肺癌组织中磷酸化AKT的表达与细胞增殖检测
2.
HIF-1α,GLUT1 expression in non-small cell lung cancer (NSCLC) and their association with COX-2;
非小细胞肺癌中HIF-1α、GLUT1与COX-2表达的关系
3.
Expression of PTTG in non-small cell lung cancer and its relationship with PTEN and Ki-67 proteins expression;
非小细胞肺癌中PTTG的表达及其与PTEN和Ki67蛋白表达的关系
2) non small cell
非小细胞
1.
CD_4~+CD_(25)~+ regulatory T cells in peripheral blood from patients with non small cell lung cancer;
非小细胞肺癌患者外周血CD_4~+CD_(25)~+调节T细胞的检测及其临床意义
2.
Purpose To investigate the relationship between CD44v6 expression and clinicopathologic characteristics in non small cell lung carcinomas (NSCLC).
目的 探讨CD4 4v6表达与非小细胞肺癌临床病理特征之间的关系。
3.
To investigate the efficacy and toxicity of combination chemotherapy with or without TAM in treatment of non small cell lung cancer.
[目的]探讨全身化疗加或不加三苯氧胺对非小细胞肺癌(NSCLC)的疗效及毒性变化。
3) non-small-cell
非小细胞
1.
US NCCN (The National Comprehensive Cancer Network) clinical practice guidelines in oncology issued the second edition treatment programs for non-small-cell lung cancer in 2006.
美国NCCN肿瘤学临床实践指南在2006年发布了第二版非小细胞肺癌治疗方案,对于规范化治疗肺癌以及提高肺癌病人生存率和生存质量有着积极的意义。
2.
Primary lung cancer is the leading cause of cancer deaths in most industrialized countries, and non-small-cell lung cancer (NSCLC) accounts for 75-80% of primary lung cancer, and is refractory to conventional therapeutic modalities.
原发性肺癌在许多工业化国家是主要的癌症死亡原因，其中非小细胞肺癌(NSCLC)占75～80％，并且用常规疗法很难治愈。
4) non-small cell lung
非小细胞
1.
The expression of vascular endothelial growth factor,CD44v6 in non-small cell lung carcinoma;
非小细胞肺癌组织中血管内皮生长因子和变异型细胞间黏附分子的表达
2.
Late-course three-dimensional conformal concurrent chemoradiotherapy for 31 patients with non-small cell lung carcinoma;
后程三维适形同期放化疗治疗Ⅲ期非小细胞肺癌31例
3.
Objective To evaluate the efficacy of combination use of paclitaxel (PTX) and cisplatin (DDP) in the treatment of advanced non-small cell lung cancer (NSCLC).
①目的 观察紫杉醇 (PTX)联合顺铂 (DDP)治疗晚期非小细胞肺癌 (NSCLC)的效果。
5) non-small-cell lung
非小细胞肺
1.
Therapeutic evaluation of the combined chemotherapy of docetaxel and oxaliplatin in the treatment of non-small-cell lung cancer;
艾素联合艾恒治疗晚期非小细胞肺癌的疗效评价
2.
Inhibitors of epidermal growth factor receptor in the treatment of non-small-cell lung cancer;
表皮生长因子受体抑制剂在非小细胞肺癌治疗中的应用
3.
Advances in the study of precise radiotherapy for non-small-cell lung cancer;
非小细胞肺癌精确放射治疗研究进展
6) non-small cell lung
非小细胞肺
1.
Clinicopathologic research on the expression of leptin and its fuctional receptor OB-Rb in non-small cell lung cancer;
瘦素及其功能性受体OB-Rb在非小细胞肺癌表达的临床病理研究
2.
The methylation status of TMS1 gene in non-small cell lung cancer and its clinical significance;
非小细胞肺癌中TMS1基因甲基化检测
3.
Advanced non-small cell lung cancer treated with gefitinib:Clinical analysis of 57 elderly patients;
吉非替尼治疗老年晚期非小细胞肺癌57例临床分析
补充资料：非允许细胞
分子式：
CAS号：
性质： (一)这是一种对限制性的致死突变株不能生长的细胞；(二)经受不住由病毒所致的溶解感染的一种细胞。
CAS号：
性质： (一)这是一种对限制性的致死突变株不能生长的细胞；(二)经受不住由病毒所致的溶解感染的一种细胞。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条